[HTML][HTML] Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients
Background ST-segment elevation myocardial infarction (STEMI) patients are treated with
dual antiplatelet therapy comprising aspirin and a P2Y 12 inhibitor. Clopidogrel is widely …
dual antiplatelet therapy comprising aspirin and a P2Y 12 inhibitor. Clopidogrel is widely …
Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients
AM Al-Rubaish, FA Al-Muhanna… - International Journal …, 2021 - discovery.ucl.ac.uk
BACKGROUND: ST-segment elevation myocardial infarction (STEMI) patients are treated
with dual antiplatelet therapy comprising aspirin and a P2Y12 inhibitor. Clopidogrel is widely …
with dual antiplatelet therapy comprising aspirin and a P2Y12 inhibitor. Clopidogrel is widely …
Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients
AM Al-Rubaish, FA Al-Muhanna… - International …, 2021 - internationaljournalofcardiology.com
Background ST-segment elevation myocardial infarction (STEMI) patients are treated with
dual antiplatelet therapy comprising aspirin and a P2Y 12 inhibitor. Clopidogrel is widely …
dual antiplatelet therapy comprising aspirin and a P2Y 12 inhibitor. Clopidogrel is widely …
Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients
AM Al-Rubaish, FA Al-Muhanna, AM Alshehri… - 2021 - pubmed.ncbi.nlm.nih.gov
Background ST-segment elevation myocardial infarction (STEMI) patients are treated with
dual antiplatelet therapy comprising aspirin and a P2Y 12 inhibitor. Clopidogrel is widely …
dual antiplatelet therapy comprising aspirin and a P2Y 12 inhibitor. Clopidogrel is widely …
[PDF][PDF] Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients
AM Al-Rubaish, FA Al-Muhanna, AM Alshehri… - core.ac.uk
Background: ST-segment elevation myocardial infarction (STEMI) patients are treated with
dual antiplatelet therapy comprising aspirin and a P2Y12 inhibitor. Clopidogrel is widely …
dual antiplatelet therapy comprising aspirin and a P2Y12 inhibitor. Clopidogrel is widely …
[PDF][PDF] Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients
AM Al-Rubaish, FA Al-Muhanna, AM Alshehri… - scholar.archive.org
Background: ST-segment elevation myocardial infarction (STEMI) patients are treated with
dual antiplatelet therapy comprising aspirin and a P2Y12 inhibitor. Clopidogrel is widely …
dual antiplatelet therapy comprising aspirin and a P2Y12 inhibitor. Clopidogrel is widely …
Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients
AM Al-Rubaish, FA Al-Muhanna… - International …, 2021 - researchinformation.amsterdamumc …
BACKGROUND: ST-segment elevation myocardial infarction (STEMI) patients are treated
with dual antiplatelet therapy comprising aspirin and a P2Y12 inhibitor. Clopidogrel is widely …
with dual antiplatelet therapy comprising aspirin and a P2Y12 inhibitor. Clopidogrel is widely …
Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients
AM Al-Rubaish, FA Al-Muhanna… - … Journal of Cardiology, 2021 - ksascholar.dri.sa
Background: ST-segment elevation myocardial infarction (STEMI) patients are treated with
dual antiplatelet therapy comprising aspirin and a P2Y 12 inhibitor. Clopidogrel is widely …
dual antiplatelet therapy comprising aspirin and a P2Y 12 inhibitor. Clopidogrel is widely …
Bedside testing of CYP2C19 vs. conventional clopidogrel treatment to guide antiplatelet therapy in ST-segment elevation myocardial infarction patients.
AM Al-Rubaish, FA Al-Muhanna… - … Journal of Cardiology, 2021 - europepmc.org
Background ST-segment elevation myocardial infarction (STEMI) patients are treated with
dual antiplatelet therapy comprising aspirin and a P2Y 12 inhibitor. Clopidogrel is widely …
dual antiplatelet therapy comprising aspirin and a P2Y 12 inhibitor. Clopidogrel is widely …